Abstract 516: AI-driven multifaceted predictive biomarkers of response to tyrosine kinase inhibition and immune checkpoint blockade in clear cell renal cell carcinoma

Clinical Research (Excluding Clinical Trials) Pub Date : 2021-07-01 DOI:10.1158/1538-7445.AM2021-516

N. Miheecheva, Y. Lyu, Akshaya Ramachandran, Danil Stupichev, A. Bagaev, E. Postovalova, K. Nomie, F. Frenkel, N. Fowler, I. AtaullakhanovRavshan, J. Hsieh

引用次数: 0

查看原文本刊更多论文

516: ai驱动的透明细胞肾细胞癌对酪氨酸激酶抑制和免疫检查点阻断反应的多方面预测生物标志物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Research (Excluding Clinical Trials)

自引率

0.00%

发文量